The boss of Sanofi France denounced this Wednesday the
"bashing"
which the laboratory has faced since announcing Covid-19: Sanofi penalized by the delay of its vaccine against Covid-19 and defended its strategic choices in the race to the vaccine.
Read also: Flu shots carry Sanofi
"I find it quite irresponsible, basically, that certain elected officials who are there to try to support their national groups, do bashing, I have had enough of 'Sanofi bashing'"
, declared on LCI Olivier Bogillot, boss of Sanofi France.
"When I hear some elected officials who are doing a bit of publicity on the back of Sanofi in the context of this crisis, I find it a little lamentable,"
he added.
"We would do exactly the same choice again"
Olivier Bogillot defended the strategic choices of the French laboratory in the race for the vaccine against Covid-19.
"If we had to redo history, in March we would do exactly the same choice"
, he said.
"We take the technology that appears to us to be the one with the most promises
.
"
"We don't choose
messenger RNA
because we don't know if it's going to work, we don't choose the adenovirus that AstraZeneca or Johnson & Johnson used because we know that this type of vaccine is effective less, moreover we see it (...) so we make this choice of adjuvanted recombinant protein, we associate with GSK, which has the best adjuvant on the market and we make a choice which is totally rational ”
, detailed Olivier Bogillot.
Read also: Covid-19: RNA vaccines should remain effective despite virus mutations
Sanofi's vaccine, developed with Britain's GSK and using recombinant protein technology, was originally announced for the summer of 2021. However, it suffered a setback after disappointing clinical trials and should finally be ready by the end. of the year.
In the meantime, Sanofi has announced that it will produce the Covid-19 vaccine from its competitors Pfizer-BioNTech in the second half of the year.